Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Phyto Teq Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct art unit and is being reviewed by 1 distinct examiner. SANTOSH SHARMA is the busiest examiner for the portfolio, holding the 1 pending office action currently active.
The company's prosecution efforts are focused entirely on this 1 pending application. Success in this matter will depend on addressing the specific technical concerns of the 1 examiner and the standards of the assigned art unit. Practitioners should prioritize this pending action to ensure the company's biotechnology research moves toward allowance. With only 1 distinct examiner involved, the prosecution strategy is highly centralized. This allows for a clear and direct response to the office action, focusing all efforts on the requirements of the art unit involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHARMA, SANTOSH | 1 | 72.8% | +29.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19182592 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | SHARMA, SANTOSH | — |
| Art Unit | Apps |
|---|---|
| 1661 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19182592 | METHOD FOR PRODUCING AGAVE CULTURES FOR TEQUILA | SHARMA, SANTOSH | 1661 | §103§112DP | Non-Final OA | — | Pending | Apr 18, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPhyto Teq Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Santosh Sharma has the most, with 1 of Phyto Teq Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
